Calidi Biotherapeutics, Inc. (CLDI)

Calidi Biotherapeutics Statistics

Total Valuation

CLDI has a market cap or net worth of $15.78 million. The enterprise value is $10.05 million.

Market Cap	15.78M
Enterprise Value	10.05M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDI has 39.65 million shares outstanding. The number of shares has increased by 855.49% in one year.

Current Share Class	37.85M
Shares Outstanding	39.65M
Shares Change (YoY)	+855.49%
Shares Change (QoQ)	+47.56%
Owned by Insiders (%)	3.48%
Owned by Institutions (%)	7.04%
Float	29.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.24
P/TBV Ratio	2.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.64.

Current Ratio	2.12
Quick Ratio	1.95
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.71

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-111.74%
Return on Invested Capital (ROIC)	-274.58%
Return on Capital Employed (ROCE)	-208.40%
Revenue Per Employee	n/a
Profits Per Employee	-$770,536
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CLDI has paid $13,000 in taxes.

Income Tax	13,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.79% in the last 52 weeks. The beta is 1.20, so CLDI's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	-82.79%
50-Day Moving Average	0.51
200-Day Moving Average	1.11
Relative Strength Index (RSI)	37.57
Average Volume (20 Days)	200,587

Short Selling Information

The latest short interest is 269,387, so 0.68% of the outstanding shares have been sold short.

Short Interest	269,387
Short Previous Month	171,127
Short % of Shares Out	0.68%
Short % of Float	0.90%
Short Ratio (days to cover)	1.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.09M
Pretax Income	-29.96M
Net Income	-21.58M
EBITDA	-19.69M
EBIT	-20.09M
Earnings Per Share (EPS)	-$0.96

Balance Sheet

The company has $10.56 million in cash and $4.71 million in debt, giving a net cash position of $5.86 million or $0.15 per share.

Cash & Cash Equivalents	10.56M
Total Debt	4.71M
Net Cash	5.86M
Net Cash Per Share	$0.15
Equity (Book Value)	7.30M
Book Value Per Share	0.32
Working Capital	6.06M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-855.49%
Shareholder Yield	-855.49%
Earnings Yield	-135.64%
FCF Yield	n/a

Analyst Forecast

The average price target for CLDI is $10.00, which is 2,412.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	2,412.56%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 15, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 15, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2